ArticleOncotarget2015

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer.

Michael T Barrett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.